A Real-World Comparative Effectiveness Trial of Treatment Strategies in Patients with Rheumatoid Arthritis: The RAPRO PRagmatic trial (RA-PROPR)

Medicine & Life Sciences

1. Age Groups 8%
2. Ambulatory Care 12%
3. Anti-Inflammatory Agents 9%
4. Biological Products 12%
5. boldenone undecylenate 18%
6. C-Reactive Protein 10%
7. Comorbidity 9%
8. Contracts 43%
9. Costs and Cost Analysis 15%
10. Deductibles and Coinsurance 20%
11. Fatigue 10%
12. Inflammation 7%
13. Injections 7%
14. Insurance Coverage 14%
15. Methotrexate 12%
16. Patient Safety 24%
17. Pharmaceutical Preparations 5%
18. Pharmaceutical Services Insurance 20%
19. Phosphotransferases 19%
20. Physicians 7%
21. Pragmatic Clinical Trials 100%
22. Prednisone 25%
23. Quality of Life 7%
24. Random Allocation 24%
25. Rheumatoid Arthritis 58%
26. Rheumatology 13%
27. Sleep 9%
28. Standard of Care 24%
29. Therapeutics 12%